Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lisata Therapeutics, Inc.

NASDAQ: LSTA · Life Sciences · 5 alerts · CIK 320017

Share price
$1.09Close, Nov 16
Market cap
$11.8M
Shares outstanding
10.8MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lisata Therapeutics, Inc. filings on SEC EDGAR ↗

4:26 PM ET 8-K
Leadership Change

Lisata Therapeutics Leadership Change

Lisata Therapeutics appointed Jeffrey Farrow to its Board of Directors as a Class III member and a member of the Audit Committee, effective October 13, 2026. The appointment expands the company's board from seven to eight members. Mr. Farrow is a veteran biopharmaceutical executive currently serving as CFO and Chief Strategy Officer of Tarsus Pharmaceuticals.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.